BioCentury | Sep 15, 2011
Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Cystic fibrosis (CF) Golgi reassembly stacking protein 2 55 kDa (GORASP2; GRASP55); cystic fibrosis transmembrane conductance regulator (CFTR) Cell culture and mouse studies suggest...
Items per page:
1 - 1 of 1